These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12474636)

  • 1. Pathophysiology of hypocitraturic nephrolithiasis.
    Hamm LL; Hering-Smith KS
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):885-93, viii. PubMed ID: 12474636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricosuric calcium nephrolithiasis.
    Sorensen CM; Chandhoke PS
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):915-25. PubMed ID: 12474638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis.
    Seltzer MA; Low RK; McDonald M; Shami GS; Stoller ML
    J Urol; 1996 Sep; 156(3):907-9. PubMed ID: 8709360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of citric acid in primary hyperparathyroidism with renal lithiasis.
    Alvarez-Arroyo MV; Traba ML; Rapado A; de la Piedra C
    Urol Res; 1992; 20(1):88-90. PubMed ID: 1736494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrate and renal calculi.
    Pak CY
    Miner Electrolyte Metab; 1987; 13(4):257-66. PubMed ID: 3306318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of non-pharmacological interventions on urinary citrate levels: a systematic review and meta-analysis.
    Pachaly MA; Baena CP; Buiar AC; de Fraga FS; Carvalho M
    Nephrol Dial Transplant; 2016 Aug; 31(8):1203-11. PubMed ID: 26311217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malic acid supplementation increases urinary citrate excretion and urinary pH: implications for the potential treatment of calcium oxalate stone disease.
    Rodgers AL; Webber D; de Charmoy R; Jackson GE; Ravenscroft N
    J Endourol; 2014 Feb; 28(2):229-36. PubMed ID: 24059642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.